Pre-eclampsia risk screening and prevention study
Part of Women’s health & pregnancy clinical trials.
This study is for pregnant women to check their risk of pre-eclampsia (a serious condition causing high blood pressure) using simple tests like blood work or ultrasound. It aims to help you and your doctor manage your pregnancy better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and have been checked for your risk of pre-eclampsia using standard risk factors listed by doctors in the UK.
- You had a blood test or uterine artery measurement to assess your pre-eclampsia risk during any trimester.
- You are not taking aspirin regularly before joining the study.
- Your baby does not have severe birth defects or a lack of heartbeat.
- You can provide follow-up and delivery information.
- You agree to join the study voluntarily and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at tiny living organisms in pregnancy (and related body samples) to find better ways to screen for preeclampsia. By learning early warning signs, it may help doctors identify risk sooner during routine prenatal care.
This study collects samples from pregnant people with preeclampsia (a serious pregnancy blood-pressure condition) and from healthy pregnancy controls. Researchers will study tiny particles (“exosomes”) to see how they differ and whether these signals could help explain or improve care for preeclampsia.
This study looks at the placenta and the area where the baby meets the mother's body to understand preeclampsia, a serious pregnancy complication. If you are between 9 and 15 weeks pregnant with one baby and are already scheduled for a placenta test, you may be able to join.
This study tests if certain blood markers can help diagnose and monitor preeclampsia. It aims to improve how this serious pregnancy condition is detected and treated.
This study tests a tool (called fullPIERS) that uses common lab tests and vital signs to predict if a pregnant person with preeclampsia might have serious complications. It helps doctors identify who needs closer monitoring.
This trial tests whether measuring two pregnancy blood markers (sFlt1 and PlGF) and planning delivery timing can help prevent preeclampsia as you reach term. It may help reduce risk for mother and baby by guiding when to deliver based on test results.
Hear when a new Preeclampsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.